Serum-high-density-lipoprotein in diabetic patients

Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis.

Diabetic medicine : a journal of the British Diabetic Association·2018

CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate.

Oral diseases·2016

Metabolic syndrome exacerbates inflammation and bone loss in periodontitis.

Journal of dental research·2014

Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Journal of dental research·2013

Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease.

Journal of periodontal research·2013

A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases.

Journal of periodontal research·2008

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Alcohol-Related Liver Disease After Metabolic Bariatric Surgery: Reassessing the Hidden Risk-A Meta-Analysis.

Obesity surgery·2026

Selenium Nanoparticles Alleviate Intestinal Epithelial Barrier Dysfunction by Coordinating Mitochondria-lysosome Communication under Dual Organelle Stress.

Biological trace element research·2026

Targeting Mitochondrial Complex I Protects Against Palmitic Acid-Induced Endothelial Dysfunction.

Diabetes, obesity & metabolism·2026

Dietary fatty acids modulate lipolytic enzymes via distinct allosteric and exosite mechanisms: An integrated in vivo and in silico study linking Cafeteria diet-induced obesity to altered lipid metabolism.

Biochemical and biophysical research communications·2026

The Implications of Lipoprotein(a) in MASLD.

Current cardiology reports·2026

Waist circumference partially mediates the non-linear association between TyHGB and MASLD in non-diabetic Japanese adults.

Frontiers in nutrition·2026

Related Experiment Videos

Serum-high-density-lipoprotein in diabetic patients

Related Concept Videos

Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis.

CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate.

Metabolic syndrome exacerbates inflammation and bone loss in periodontitis.

Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease.

A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Alcohol-Related Liver Disease After Metabolic Bariatric Surgery: Reassessing the Hidden Risk-A Meta-Analysis.

Selenium Nanoparticles Alleviate Intestinal Epithelial Barrier Dysfunction by Coordinating Mitochondria-lysosome Communication under Dual Organelle Stress.

Targeting Mitochondrial Complex I Protects Against Palmitic Acid-Induced Endothelial Dysfunction.

Dietary fatty acids modulate lipolytic enzymes via distinct allosteric and exosite mechanisms: An integrated in vivo and in silico study linking Cafeteria diet-induced obesity to altered lipid metabolism.

The Implications of Lipoprotein(a) in MASLD.

Waist circumference partially mediates the non-linear association between TyHGB and MASLD in non-diabetic Japanese adults.

Related Experiment Videos

Serum-high-density-lipoprotein in diabetic patients

Related Concept Videos

Related Articles